A series of rhodanine derivatives bearing 4-(furan-2-yl)benzoic acid moiety were synthesized and studied as inhibitors of xanthine oxidase. This enzyme is a known target for allopurinol and febuxostat used in the treatment of hyperuricemia, gout, and other diseases. The synthesized compounds with different substituents in position 3 of the rhodanine ring showed in vitro inhibitory activities towards xanthine oxidase in a low micromolar concentration range. The 4-(furan-2-yl)benzoic acid derivative with a fragment of N-unsubstituted rhodanine was found to have the lowest IC50 value which does not depend on the presence of albumin or Tween-80 under the assay conditions. According to kinetic data, the rhodanine-based 4-(furan-2-yl)benzoic acid was a mixed-type inhibitor with the same affinity for the free enzyme and the enzyme-substrate complex. Molecular docking and molecular dynamic studies were performed to elucidate the binding mode of this compound in the active site of xanthine oxidase
A thirteen 4-cyano-2-phenyl-1,3-oxazole-5-sulfonamide analogs have been synthesized and characterized by spectroscopy methods, elemental analysis. Their growth inhibiting activity was determined in vitro in the one dose assay against the total NCI-60 human cancer cell line panel. The five-dose analysis was performed on the six compounds with greater cytotoxicity. Two compounds 8 and 9 exhibited the greatest potency against total NCI-60 cancer cell lines in the five dose assay. Furthermore, compound 9 with 3-methylpiperidine fragment turned out to be two times more active than compound 8 with 4-methylpiperidine (GI50 = 1.4±0.1 against 2.5±0.4, GI = 3.9±0.6 against 7.1±1.3 and LC50 = 7.1±1.0 against 16.4±2.3 µM). The lack of commonly used drugs that show a high correlation with the majority of analyzed compounds, based on two out of three calculated parameters of anticancer potency, suggests that they may interact with a unique target. The ADMET analysis results predict that this compound meets the drug similarity criteria and does not belong to interfering molecules that react non-specifically with numerous targets. The prediction of lead likeness for all compounds is also included, meaning that any of them can be optimized to enhance selectivity and other pharmacological properties that characterize their chemotherapeutic potential
1 January 2018 in Baltic Journal of Economic Studies
The discovery of nucleoside antibiotics gave impetus to the development of the chemistry of pyrrolo[2,3-d]pyrimidines and thieno[2,3-d]pyrimidines as biologically active compounds. This work describes a universal and efficient approach to the synthesis of new pyrrolo[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives of piperazin-1-yl-1,3-oxazole-4-carbonitriles. Their potential as biologically active compounds is considered and ADMET-score is predicted to assess their further application as pharmaceutical substances